|
HY-N1356A-1mg
|
MedChemexpress LLC
|
(R)-Reticuline [CAS 3968-19-2]
|
|
|
|
|
HY-N1356A-5mg
|
MedChemexpress LLC
|
(R)-Reticuline [CAS 3968-19-2]
|
|
|
|
|
HY-139553A-1mg
|
MedChemexpress LLC
|
(R)-Zunsemetinib [CAS 1640282-44-5]
|
|
|
|
|
HY-139553A-10mg
|
MedChemexpress LLC
|
(R)-Zunsemetinib [CAS 1640282-44-5]
|
|
|
|
|
HY-139553A-25mg
|
MedChemexpress LLC
|
(R)-Zunsemetinib [CAS 1640282-44-5]
|
|
|
|
|
HY-139553A-5mg
|
MedChemexpress LLC
|
(R)-Zunsemetinib [CAS 1640282-44-5]
|
|
|
|
|
HY-139553A-50mg
|
MedChemexpress LLC
|
(R)-Zunsemetinib [CAS 1640282-44-5]
|
|
|
|
|
HY-125904-1mg
|
MedChemexpress LLC
|
4-Hydroxyretinoic acid [CAS 66592-72-1]
|
|
|
|
|
HY-125904-5mg
|
MedChemexpress LLC
|
4-Hydroxyretinoic acid [CAS 66592-72-1]
|
|
|
|
|
HY-153671-10mg
|
MedChemexpress LLC
|
4'-Methyl-Beta-naphthoflavone [CAS 1282513-75-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-153671-100mg
|
MedChemexpress LLC
|
4'-Methyl-Beta-naphthoflavone [CAS 1282513-75-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-153671-25mg
|
MedChemexpress LLC
|
4'-Methyl-Beta-naphthoflavone [CAS 1282513-75-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-153671-5mg
|
MedChemexpress LLC
|
4'-Methyl-Beta-naphthoflavone [CAS 1282513-75-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-153671-50mg
|
MedChemexpress LLC
|
4'-Methyl-Beta-naphthoflavone [CAS 1282513-75-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-117095-100mg
|
MedChemexpress LLC
|
4-Methylumbelliferyl oleate [CAS 18323-58-5]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-117095-25mg
|
MedChemexpress LLC
|
4-Methylumbelliferyl oleate [CAS 18323-58-5]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-117095-50mg
|
MedChemexpress LLC
|
4-Methylumbelliferyl oleate [CAS 18323-58-5]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-113962-1mg
|
MedChemexpress LLC
|
7Alpha,25-Dihydroxycholesterol [CAS 64907-22-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-113962-10mg
|
MedChemexpress LLC
|
7Alpha,25-Dihydroxycholesterol [CAS 64907-22-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-113962-100mg
|
MedChemexpress LLC
|
7Alpha,25-Dihydroxycholesterol [CAS 64907-22-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-113962-25mg
|
MedChemexpress LLC
|
7Alpha,25-Dihydroxycholesterol [CAS 64907-22-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-113962-5mg
|
MedChemexpress LLC
|
7Alpha,25-Dihydroxycholesterol [CAS 64907-22-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-113962-50mg
|
MedChemexpress LLC
|
7Alpha,25-Dihydroxycholesterol [CAS 64907-22-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-104001-1mg
|
MedChemexpress LLC
|
BAY-524 [CAS 1445830-39-6]
|
|
Cancer-programmed cell death
|
|
|
HY-104001-10mg
|
MedChemexpress LLC
|
BAY-524 [CAS 1445830-39-6]
|
|
Cancer-programmed cell death
|
|
